ALNY
Alnylam Pharmaceuticals Inc.
$458.92
+$5.36(+1.18%)
70
Overall
40
Value
100
Tech
--
Quality
Market Cap
$59.45B
Volume
971.74K
52W Range
$205.87 - $484.21
Target Price
$465.67
Key Metrics Overview
| Market Cap | $59.45B | P/E Ratio | 546.33 |
| 52W High | $484.21 | 52W Low | $205.87 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 32.9% | 52W Position | 90.9% |
| Overall Score | 70 | Value Score | 40 |
| Quality Score | -- | Technical Score | 100 |
Growth Analysis
| EPS Current Est | $0.84 | EPS Next Est | $5.98 |
| EPS Growth Est | +611.9% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $458.92 | +1.2% | 971.74K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW